FY2025 (Year ending March 2026)
-
May. 13, 2025
FY2024 (Year ending March 2025)
-
Mar. 27, 2025
-
Mar. 24, 2025
-
Mar. 21, 2025
Sysmex and J TEC Sign a Research Collaboration Agreement
Regarding Sterility Testing in Regenerative Medicine and Cell Therapy
-
Jan. 30, 2025
-
Dec. 16, 2024
-
Dec. 5, 2024
-
Oct. 1, 2024
-
Sep. 17, 2024
-
Sep. 5, 2024
-
Jun. 17, 2024
FY2023 (Year ending March 2024)
-
Feb. 28, 2024
-
Dec. 25, 2023
-
Apr. 21, 2023
FY2022 (Year ending March 2023)
-
Mar. 28, 2023
Notice of press release from Nagoya University
Nagoya University and Chulalongkorn University, Collaboration in Thailand Successful treatment of malignant lymphoma using non-viral vector-based CAR-T cells
-
Mar. 17, 2023
-
Sep. 27, 2022
-
Aug. 15, 2022
-
Aug. 8, 2022
Supporting the Early Commercialization of Regenerative Medicine for Corneal Endothelium
— Partial Product Development Contract with ActualEyes Inc. —
-
Aug. 5, 2022
– With a grant from JSAAE, 6 corporations continue contributing jointly to the cosmetics industry –
-
Jul. 5, 2022
-
Apr. 27, 2022
-
Apr. 27, 2022
FY2021 (Year ending March 2022)
-
Mar. 30, 2022
— J-TEC commissioned with contract manufacture of the IP —
-
Jan. 26, 2022
10th Technology and Management/Innovation Award “METI Minister's Award” Winner
“Popularization of Japan’s First Regenerative Medical Product – Autologous Cultured Epidermis JACE”
-
Nov. 25, 2021
Announcement of Start of Clinical Trial for Allogeneic Cultured Epidermis “Allo-JaCE03”
- J-TEC’s first allogeneic cell therapy product: Submitted notification of clinical trial plan to realize ready-made product that can be swiftly provided to patients -
-
Sep. 15, 2021
Announcing approval of Autologous Cultured Oral Mucosal Epithelium “Ocural” for NHI listing
Listing effective December 1 creates new option for treatment of bilateral limbal stem cell deficiency
-
Aug. 25, 2021
-
Jun. 17, 2021
Marketing approval obtained for Autologous Cultured Oral Mucosal Epithelium “Ocural”
— World’s first regenerative medical product using oral mucosal epithelial cells for the treatment of limbal stem cell deficiency —
-
May. 24, 2021
FY2020 (Year ending March 2021)
-
Mar. 9, 2021
-
Sep. 14, 2020
FY2019 (Year ending March 2020)
FY2018 (Year ending March 2019)
-
Mar. 20, 2019
- First application for a regenerative medical product in the field of ophthalmology in Japan -
-
Jan. 7, 2019
-
Jul. 19, 2018
-
Jul. 17, 2018
-
Jul. 3, 2018
-
Jun. 21, 2018
FY2015 (Year ending March 2016)
-
Oct. 13, 2015
-
May. 20, 2015
FY2014 (Year ending March 2015)
-
Dec. 18, 2014
-
Oct. 30, 2014
FY2013 (Year ending March 2014)
FY2012 (Year ending March 2013)
-
Jul. 30, 2012
FY2011 (Year ending March 2012)
-
Apr. 28, 2011
FY2010 (Year ending March 2011)
-
Dec. 1, 2010
-
Sep. 15, 2010
-
Aug. 30, 2010
-
Apr. 30, 2010
FY2009 (Year ending March 2010)
-
Aug. 24, 2009
-
Apr. 30, 2009
FY2008 (Year ending March 2009)
-
Jan. 7, 2009
On January 1 2009, J-TEC's autologous cultured epidermis "JACE" was listed as an item covered by the National Health Insurance in Japan.
-
Dec. 17, 2008
J-TEC has received reimbursement approval for the autologous cultured epidermis "JACE" in Japan. The reimbursement will start in Janurary 2009.
-
May. 14, 2008
FY2007 (Year ending March 2008)
-
Dec. 21, 2007
J-TEC joined the Jasdaq Securities Exchange's Neo market for venture firms on December 21, 2007.
-
Nov. 1, 2007
On October 29, 2007, J-TEC officially received government approval to culture and sell autologous cultured epidermis JACE for serious burns treatment in Japan.
-
Oct. 3, 2007
J-TEC got the go-ahead by the health ministry panel of the Ministry of Health, Labor and Welfare, for the manufacturing & sales approval of cultured epidermis in Japan.
FY2006 (Year ending March 2007)
-
Nov. 21, 2006
Awarded the highest prize in the New Business Awards 2006, sponsored by the Chubu Economic Federation.
FY2005 (Year ending March 2006)
-
Oct. 19, 2005
J-TEC awarded the Japan Bioventure Grand Prize, the top honor in the 4th Japan Bioventure Grand Prize awards.
FY2004 (Year ending March 2005)
-
Mar. 29, 2005
-
Jun. 30, 2004
Awarded President of the Science Council of Japan's Award at the 16th Awards for Excellence in Collaboration Between Industry, Academia, and Government.
FY2003 (Year ending March 2004)
-
Feb. 6, 2004
Obtained authorization to begin clinical trials of autologous cultured cartilage.
-
Sep. 26, 2003
Started multicenter clinical trials of autologous cultured epidermis.
FY1998 (Year ending March 1999)
-
Feb. 5, 1999
Japan Tissue Engineering Co., Ltd established.